It is a matter of execution. Would you have confidence in this team to get approved, ramp up staffing in sales/ administration, set up logistics, market this drug for gbm (forget tissue agnostic and trials needed, never happening under this crew). At this point, the market is saying no and i don't blame them given how far they have progressed. What experience do they have in any of this regulatory and commercialization space? None that i'm aware of if you check their bios. If they can get Uk submission, I think that is the end of the line for this team. This team bless their hearts are in over their head. It should never take this long to submit an application. The SP will not move until the mgmt can show progress toward commercialization and they ain't even close yet otherwise they would be ramping up sales and administrative staff ( and not that doesn't mean advent staff). Everyone here guesses or blindly pumps because this company doesn't even have a corporate presentation ( usually my go to to see what's going on with the company) or do quarterly updates (where you would check progress in completed milestones/upcoming milestones).
News 
Market Data 
Discover 
AI
